Pilo Shlomo 4
4 · Raphael Pharmaceutical Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Pilo Shlomo
DirectorChief Executive Officer10% Owner
Transactions
- Award
Warrant to purchase Common Stock
2025-03-02+100,000→ 1,100,000 totalExercise: $1.00Exp: 2026-07-15→ Common Stock (100,000 underlying) - Award
Common Stock
2025-03-02$0.50/sh+200,000$100,000→ 3,983,701 total
Footnotes (1)
- [F1]200,000 shares of Common Stock and 100,000 Warrants to purchase Common Stock of the issuer were acquired by the reporting person for a combined purchase price of $0.50 per share of Common Stock and accompanying Warrant to purchase Common Stock. The Warrants are exercisable immediately and will expire on July 15, 2026.